RMD Technical Analysis



As of date:11/1/2024
RMD stock price:244.28
RMD 50 DMA:242.27
RMD 200 DMA:209.24
RMD MACD (200-50):-33.03
RMD RSI:54.37
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)54.37
Extremely
Oversold

Also see:
RMD Market Cap History
RMD Shares Outstanding History
RMD YTD Return

Quotes delayed 20 minutes

Email EnvelopeFree RMD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Open Lending (LPRO) Shares Cross Above 200 DMA
53 minutes ago


TWST Crosses Above Key Moving Average Level
53 minutes ago


Magic Software Enterprises (MGIC) Shares Cross Below 200 DMA
1 hour, 10 minutes ago


Bullish Two Hundred Day Moving Average Cross - FIZZ
1 hour, 10 minutes ago


TRS Makes Notable Cross Below Critical Moving Average
1 hour, 12 minutes ago


Notable Two Hundred Day Moving Average Cross - VTRS
1 hour, 24 minutes ago


Western Midstream Partners (WES) Shares Cross Below 200 DMA
1 hour, 27 minutes ago


Enfusion Breaks Below 200-Day Moving Average - Notable for ENFN
1 hour, 27 minutes ago


CPA Makes Notable Cross Below Critical Moving Average
1 hour, 41 minutes ago


Stantec Breaks Above 200-Day Moving Average - Bullish for STN
1 hour, 41 minutes ago


BMO Makes Notable Cross Below Critical Moving Average
1 hour, 44 minutes ago


KRBN Breaks Above 200-Day Moving Average - Bullish for KRBN
1 hour, 44 minutes ago


XLV Crosses Critical Technical Indicator
1 hour, 44 minutes ago


Universal Insurance Holdings (UVE) Shares Cross Below 200 DMA
1 hour, 44 minutes ago


ERO Stock Crowded With Sellers
1 hour, 44 minutes ago


More Technical Analysis News

RMD Technical AnalysisRMD RSI
ResMed is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep-disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Co.'s operating segments are: Sleep and Respiratory Care, which relates primarily to the sale of its products that are therapy-based equipment; and Software as a Service, which relates to the provision of software access with ongoing support and maintenance services as well as services such as training and consulting.

When researching a stock like ResMed, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from RMD Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for RMD stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
RMD DMARMD MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ResMed (RMD) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

RVTY Technical Analysis
SOLV Technical Analysis
STE Technical Analysis
SYK Technical Analysis
TECH Technical Analysis
TFX Technical Analysis
TMO Technical Analysis
UHS Technical Analysis
VRTX Technical Analysis
VTRS Technical Analysis
More Healthcare companies »

 

RMD Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2024, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.